What exactly is Retatrutide (also called “Reta”), and where does the 10mg tier fit?
Retatrutide (commonly searched as “Reta”) is a triple-agonist synthetic peptide at the GLP-1, GIP, and glucagon receptors, studied in pre-clinical metabolic-axis models. The 10mg per vial tier sits in the middle of the six-tier ladder (5, 10, 20, 30, 40, 60 mg) — it is the most common starting point for dose-response designs that need working concentrations between 250 and 2000 mcg without reconstituting a larger vial each session.
What does this specific lot’s CoA cover?
Every lot is independently assayed by reverse-phase HPLC for purity and by mass-spec for identity against theoretical mass. Lot-specific certificates of analysis are being catalogued and will be publicly listed on the product page as they come online.
How do I reconstitute a 10mg Retatrutide vial?
- Wipe the vial stopper with an alcohol swab.
- Draw 1 to 2 mL of bacteriostatic water (target concentration determines volume).
- Inject the diluent slowly against the vial wall — do not aim at the peptide cake.
- Swirl gently to dissolve. Do not shake.
- Store the reconstituted vial at 2 to 8 °C. Use within 30 days.
Should I order the 10mg tier or a different size?
Cohort size and per-dose volume drive the choice. Smaller dose-response studies typically start at 5mg or 10mg. Higher-throughput designs move to 20 to 60 mg per vial to reduce per-vial reconstitution overhead. All six tiers ship as kits of 10 vials or single vials.
How is Retatrutide different from Tirzepatide?
Tirzepatide is a dual GLP-1 / GIP agonist. Retatrutide adds a third arm at the glucagon receptor. The pre-clinical metabolic-axis literature treats that third activity as the mechanistic distinction between the two molecules.
What ships in the box, and how fast?
- 10 lyophilized Retatrutide 10mg vials
Orders placed before 14:00 PT ship the same business day from our British Columbia facility. Canadian orders arrive in 2 to 4 business days after dispatch.
